Article
The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia.
Nature structural biology - 1 Apr 1999
Guenther B D, Sheppard C A, Tran P, Rozen R, Matthews R G, Ludwig M L
Abstract excerpt
Elevated plasma homocysteine levels are associated with increased risk for cardiovascular disease and neural tube defects in humans. Folate treatment decreases homocysteine levels and dramatically reduces the incidence of neural tube defects. The flavoprotein methylenetetrahydrofolate reductase (MTHFR) is a likely target for these actions of folate. The most common genetic cause of mildly elevated plasma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
